Berkeley Lights

Berkeley Lights serves a diverse range of clients, including pharmaceutical companies, biotechnology firms, and research institutions. These clients are engaged in various fields such as antibody discovery, viral neutralization, cell line development, cell therapy development, and synthetic biology. The company's primary offering is the Berkeley Lights Platform, an integrated system that includes proprietary consumables like OptoSelect chips and reagent kits, advanced automation systems, and specialized application software.

The core technology behind Berkeley Lights' platform is optofluidics, which combines light and fluidics to manipulate and analyze cells with high precision. This technology allows clients to sift through thousands of cells simultaneously, providing deep profiling and detailed data on cell characteristics. This capability significantly reduces the time and effort required for cell-based research and development, enabling faster breakthroughs in disease treatment and other biological discoveries.

Berkeley Lights' business model revolves around selling its integrated platform and consumables to clients, as well as providing ongoing support and software updates. The company generates revenue through the sale of these products and services, which are essential for clients to conduct their research and development activities efficiently.

In summary, Berkeley Lights is a pioneering company that leverages advanced optofluidic technology to facilitate rapid and precise cell analysis and development. By offering a comprehensive platform that integrates hardware, consumables, and software, the company helps its clients achieve faster and more accurate results in their quest to cure diseases and develop new therapies.